论文部分内容阅读
中国已经“入世”,药业如何应对?眼下,悲观主义者大有人在。有人紧张:整个中国药业的年销售额还比不上世界制药巨头默克公司一家,入世后,大多数中国医药企业连GMP或GSP都尚未通过认证,半数左右的中小型医药企业今天生存已属不易,面对洋药业的侵犯,将会显得不堪一击;
China has “joined the WTO”, how to deal with medicine? Right now, there are a lot of pessimists. Someone nervous: the annual sales of the entire Chinese pharmaceutical industry is still less than the world pharmaceutical giant Merck a company, after China’s accession to the WTO, most Chinese pharmaceutical companies even GMP or GSP have not been certified, about half of the small and medium-sized pharmaceutical companies have survived Is not easy, in the face of foreign medicine violations, will be vulnerable;